Viral infection linked to juvenile diabetes

May 24, 2010

Researchers from Italy have found a statistically significant association between enteroviral infection and diagnosis of type-1 diabetes in children. They report their findings today at the 110th General Meeting of the American Society for Microbiology in San Diego, California.

Type 1 diabetes, also called juvenile diabetes or insulin-dependent diabetes, is a disorder of the body's immune system. The patient's own immune system is somehow activated to slowly destroy insulin-producing in the pancreas until the patient's body cannot produce insulin anymore. People diagnosed with type-1 diabetes require lifelong insulin therapy. Approximately 13,000 young people are diagnosed in the United States each year.

Type 1 diabetes develops in individuals who are genetically susceptible. An exposure to some yet unknown triggering environmental factor or factors may be required.

"We studied the possible association of enterovirus infections with type-1 diabetes at time of diagnosis," says Antonio Toniolo of the University of Insubria and Ospedale di Circolo in Verese, Italy, a researcher on the study. "Literature suggests that infection by different enteroviruses may be linked to the early stages of diabetes."

Toniolo and his colleagues tested the blood of 112 children at the time of time of diagnosis for the existence of enteroviral DNA. All the children, ranging in age from 2-16 years, were patients at the Pediatric Endocrinology Units of Varese and Pisa. Low-level enteroviral infectivity and genome fragments were detected in 83% of type-1 diabetes patients, compared to only 7% of healthy controls.

"These data do not provide a causal relationship between enterovirus infections and diabetes," warns Toniolo. "However, the high prevalence of enteroviral genome sequences in newly diagnosed type-1 diabetes cases indicate that different enterovirus types represent a significant of early stage juvenile diabetes."

If similar results could be obtained in patient populations in other geographic areas, early enterovirus detection could help lead researchers to identify other environmental factors that lead to development and maybe one day innovative methods for prevention or treatment, says Toniolo.

Explore further: Experimental Ebola drug heals all monkeys in study (Update)

Provided by American Society for Microbiology

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Dramatic increase of Type 1 diabetes in under fives

Mar 16, 2007

Researchers are calling for more work in to the reasons behind a big increase of young children with Type 1 diabetes. A new study, led by Bristol University, has discovered that the number of children under five-years-old ...

FDA approves new diabetes treatment

Oct 17, 2006

The U.S. Food and Drug Administration has approved the use of Januvia tablets as the first in a new class of diabetes drugs.

Recommended for you

Ebola in mind, US colleges screen some students

11 hours ago

University students from West Africa may be subject to extra health checks when they arrive to study in the United States as administrators try to insulate their campuses from the worst Ebola outbreak in ...

WHO: More Ebola cases in past week than any other

12 hours ago

The past week has seen the highest increase of Ebola cases since the outbreak in West Africa began, the World Health Organization said Friday, offering more evidence that the crisis is worsening.

User comments : 0